Parabilis Medicines, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
FMR LLC, through its subsidiaries, has disclosed beneficial ownership of 8.5% of Parabilis Medicines Inc.'s common stock as of June 30, 2026.